Early-Phase Study Aims to Reduce GVHD Risk in Patients Undergoing Transplant

(MedPage Today) -- A phase Ib study evaluating the efficacy, safety, and pharmacokinetics of SER-155 in adults undergoing allogeneic hematopoietic stem cell transplantation to reduce the risk of infection and graft-versus-host disease (GVHD) was...